Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

Go back to Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
(NASDAQ: CMND) Delayed: 1.03 -0.13 (11.21%)
Previous Close $1.16    52 Week High
Open $1.15    52 Week Low
Day High $1.15    P/E N/A 
Day Low $0.92    EPS
Volume 3,049,057